« Pharma Flock Begins Migration |
| Special Off-Topic Weekend Irrelevancy »
October 29, 2004
Different or Not? You Tell Me.
Yesterday's post suggests a question for the audience. The whole reason that big companies put up these satellite sites is to tap into a different labor force and generate ideas that wouldn't necessarily have happened back at the Mothership. I know that I have readers at Novartis-Cambridge and J&J-La Jolla, among other scattered sites, so here's my query: Does this work at all?
Does the hoped-for cross-fertilization take place between these sites and the academic/biotech environment they sit in? Is the work force really different from the people at the main site? And is there any not-invented-here rivalry between them? Are things really done differently, or does the corporate culture still permeate?
I'm particularly interested in hearing from people who've worked at both the main research site and the newer ones - I realize, though, that that isn't a big fraction of the work force at these places. Those of you who work at companies with research split between Europe and the US have some insights to offer, too, I think.
+ TrackBacks (0) | Category: Drug Industry History
- RELATED ENTRIES
- XKCD on Protein Folding
- The 2014 Chemistry Nobel: Beating the Diffraction Limit
- German Pharma, Or What's Left of It
- Sunesis Fails with Vosaroxin
- A New Way to Estimate a Compound's Chances?
- Meinwald Honored
- Molecular Biology Turns Into Chemistry
- Speaking at Northeastern